ArticleProceedings of the National Academy of Sciences of the United States of America2016

Growth hormone-releasing hormone receptor antagonists inhibit human gastric cancer through downregulation of PAK1-STAT3/NF-κB signaling.

Jinfeng Gan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.